ArticleArteriosclerosis, thrombosis, and vascular biology2026
Murine Aortopulmonary Shunt Model of Flow-Driven Pulmonary Hypertension-Brief Report.
Article in Arteriosclerosis, thrombosis, and vascular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundChronic left-to-right shunting, as occurs with congenital heart disease or persistent ductus-like flow, exposes pulmonary circulation to sustained high-flow shear and pulsatile pressure and causes severe, flow-mediated arteriopathy. A scalable, minimally invasive mouse model that reproduces this hemodynamic trigger is needed to enable mechanistic dissection in a genetically tractable system.
methodsAn ultrasound-guided transcatheter aortopulmonary shunt procedure was developed to create ductus-like communication between the aortic arch and pulmonary artery. Shunt formation and patency were confirmed by B-mode echocardiography with color and pulsed-wave Doppler. Hemodynamics and right ventricular function were assessed by transthoracic echocardiography and closed-chest micromanometer catheterization at 1 month after surgery. A subset of animals was analyzed at 14 days for early endothelial plasticity. Bulk RNA sequencing of pulmonary arteries was performed to define transcriptional remodeling associated with shunt-driven disease.
resultsTranscatheter aortopulmonary shunt produced a sustained left-to-right overcirculation with Doppler-confirmed shunt flow, which induced pulmonary artery hypertension with elevated right ventricular systolic pressure, increased pulmonary vascular load, and progressive right ventricular dilation and dysfunction. Histological analyses demonstrated robust pulmonary arterial remodeling, including medial muscularization and thickening, adventitial expansion, and perivascular fibrosis, accompanied by right ventricular cardiomyocyte hypertrophy and increased myocardial fibrosis. Transcriptomic profiling of pulmonary arteries revealed broad differential gene regulation consistent with pulmonary artery hypertension pathobiology, including inflammatory, proliferative, and profibrotic responses and increased mesenchymal/smooth muscle marker expression. Costaining endothelial and mesenchymal markers supported endothelial phenotypic transition within the remodeled pulmonary arterial wall.
conclusionsTranscatheter aortopulmonary shunt establishes a minimally invasive, reproducible murine model of shunt-driven pulmonary artery hypertension triggered by flow-mediated arteriopathy. This platform provides a versatile tool to interrogate flow-sensing mechanisms and to evaluate therapies targeting both vasoreactivity and structural remodeling in pulmonary artery hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.